Fed. Circ. Won't Revive Pfizer's Fungus Treatment Patents
The Federal Circuit has affirmed decisions by the Patent Trial and Appeal Board that invalidated four patents covering Anacor Pharmaceuticals Inc.'s fungal infection treatment Kerydin as obvious, shutting down the Pfizer...To view the full article, register now.
Already a subscriber? Click here to view full article